Long intergenic non-coding RNAs (LincRNAs) identified by RNA-Seq in breast cancer

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Ding, Xianfeng ^a   Zhu, Limin ^a   Ji, Ting ^a   Zhang, Xiping ^b   Wang, Fengmei ^c   Gan, Shaoju ^a   Zhao, Ming ^a   Yang, Hongjian ^b  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b ZHEJIANG CANCER HOSPITAL   (China)

^c Zhejiang University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LONG UNTRANSLATED RNA; PROGESTERONE RECEPTOR; PROTEIN BINDING;

ADULT; ADVANCED CANCER; AGE; ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER STAGING; CHROMOSOMAL LOCALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; PREDICTION; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; RNA STRUCTURE; BIOLOGY; BREAST TUMOR; CHROMOSOME MAP; CONFORMATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HIGH THROUGHPUT SEQUENCING; PATHOLOGY; REPRODUCIBILITY; SEQUENCE ANALYSIS;

BREAST NEOPLASMS; CHROMOSOME MAPPING; COMPUTATIONAL BIOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; NUCLEIC ACID CONFORMATION; PROTEIN BINDING; REPRODUCIBILITY OF RESULTS; RNA, LONG NONCODING; SEQUENCE ANALYSIS, RNA;

EID: 84905509806     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0103270     Document Type: Article

References (42)

1. Birney E, Stamatoyannopoulos JA, Dutta A, Guigó R, Gingeras TR, et al. (2007) Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 447: 799-816. (Pubitemid 46920138)
2. Khalil AM, Guttman M, Huarte M, Garber M, Raj A, et al. (2009) Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proceedings of the National Academy of Sciences 106: 11667-11672.
3. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, et al. (2010) Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature 464: 1071-1076.
4. Penny GD, Kay GF, Sheardown SA, Rastan S, Brockdorff N (1996) Requirement for Xist in X chromosome inactivation. Nature 379: 131-137. (Pubitemid 26020194)
5. Yoon JH, Abdelmohsen K, Srikantan S, Yang X, Martindale JL, et al. (2012) LincRNA-p21 suppresses target mRNA translation. Molecular cell.
6. Ji P, Diederichs S, Wang W, Böing S, Metzger R, et al. (2003) MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 22: 8031-8041. (Pubitemid 37175867)
7. He JH, Han ZP, Li YG (2014) Association between long non-coding RNA and human rare diseases (Review). Biomedical Reports 2: 19-23.
8. Huarte M, Rinn JL (2010) Large non-coding RNAs: missing links in cancer? Human molecular genetics 19: R152-R161.
9. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA: a cancer journal for clinicians 63: 11-30.
10. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nature Reviews Cancer 6: 857-866. (Pubitemid 44629897)
11. Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends in cell biology 21: 354-361.
12. Wang Z, Gerstein M, Snyder M (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nature Reviews Genetics 10: 57-63.
13. Metzker ML (2009) Sequencing technologies - the next generation. Nature Reviews Genetics 11: 31-46.
14. Hawkins RD, Hon GC, Ren B (2010) Next-generation genomics: an integrative approach. Nature Reviews Genetics 11: 476-486.
15. Washietl S (2010) Sequence and structure analysis of noncoding RNAs. Data Mining Techniques for the Life Sciences: Springer. pp. 285-306.
16. Bernhart SH (2011) RNA Structure Prediction. In Silico Tools for Gene Discovery: Springer. pp. 307-323.
17. Muppirala UK, Honavar VG, Dobbs D (2011) Predicting RNA-protein interactions using only sequence information. BMC bioinformatics 12: 489.
18. Mardis ER (2008) Next-generation DNA sequencing methods. Annu Rev Genomics Hum Genet 9: 387-402.
19. Suzuki T, Higgins P, Crawford D (2000) Control selection for RNA quantitation. Biotechniques 29: 332-337. (Pubitemid 30658285)
20. Dhillon VS, Husain SA, Ray G (2003) Expression of aphidicolin-induced fragile sites and their relationship between genetic susceptibility in breast cancer, ovarian cancer, and non-small-cell lung cancer patients. Teratogenesis, carcinogenesis, and mutagenesis 23: 35-45. (Pubitemid 36277883)
21. Richard F, Pacyna-Gengelbach M, Schlüns K, Fleige B, Winzer KJ, et al. (2000) Patterns of chromosomal imbalances in invasive breast cancer. International journal of cancer 89: 305-310. (Pubitemid 30430749)
22. Pastural E, Ersoy F, Yalman N, Wulffraat N, Grillo E, et al. (2000) Two genes are responsible for Griscelli syndrome at the same 15q21 locus. Genomics 63: 299-306. (Pubitemid 30146662)
23. Crowther-Swanepoel D, Broderick P, Di Bernardo MC, Dobbins SE, Torres M, et al. (2010) Common variants at 2q37. 3, 8q24. 21, 15q21. 3 and 16q24. 1 influence chronic lymphocytic leukemia risk. Nature genetics 42: 132-136.
24. Liu YZ, Xiao P, Guo YF, Xiong DH, Zhao LJ, et al. (2006) Genetic linkage of human height is confirmed to 9q22 and Xq24. Human genetics 119: 295-304.
25. Öhman M, Oksanen L, Kaprio J, Koskenvuo M, Mustajoki P, et al. (2000) Genome-wide scan of obesity in Finnish sibpairs reveals linkage to chromosome Xq24. Journal of Clinical Endocrinology & Metabolism 85: 3183-3190.
26. Melchor L, Saucedo-Cuevas LP, Muñoz-Repeto I, Rodríguez- Pinilla SM, Honrado E, et al. (2009) Comprehensive characterization of the DNA amplification at 13q34 in human breast cancer reveals TFDP1 and CUL4A as likely candidate target genes. Breast Cancer Res 11: R86.
27. Shinomiya T, Mori T, Ariyama Y, Sakabe T, Fukuda Y, et al. (1999) Comparative genomic hybridization of squamous cell carcinoma of the esophagus: the possible involvement of the DP1 gene in the 13q34 amplicon. Genes, Chromosomes and Cancer 24: 337-344. (Pubitemid 29115872)
28. Dohna M, Reincke M, Mincheva A, Allolio B, Solinas-Toldo S, et al. (2000) Adrenocortical carcinoma is characterized by a high frequency of chromosomal gains and high-level amplifications. Genes, Chromosomes and Cancer 28: 145-152. (Pubitemid 30246992)
29. Michiels EM, Weiss MM, Hoovers JM, Baak JP, Voute P, et al. (2002) Genetic alterations in childhood medulloblastoma analyzed by comparative genomic hybridization. Journal of pediatric hematology/oncology 24: 205-210. (Pubitemid 34297564)
30. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, et al. (2002) TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35: 1476-1484. (Pubitemid 34966902)
31. Tsai MC, Manor O, Wan Y, Mosammaparast N, Wang JK, et al. (2010) Long noncoding RNA as modular scaffold of histone modification complexes. Science 329: 689-693.
32. Cirillo D, Agostini F, Tartaglia GG (2012) Predictions of protein-RNA interactions. Wiley Interdisciplinary Reviews: Computational Molecular Science.
33. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71. (Pubitemid 24345325)
34. Wooster R, Neuhausen SL, Mangion J, Quirk Y, Ford D, et al. (1994) Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 265: 2088-2090. (Pubitemid 24325690)
35. Osborne CK (1998) Steroid hormone receptors in breast cancer management. Breast cancer research and treatment 51: 227-238.
36. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, et al. (1987) Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182. (Pubitemid 17231334)
37. Bos JL (1989) Ras oncogenes in human cancer: a review. Cancer research 49: 4682-4689.
38. Li J, Yen C, Liaw D, Podsypanina K, Bose S, et al. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275: 1943-1947. (Pubitemid 27148818)
39. Balkwill F (2006) TNF-α in promotion and progression of cancer. Cancer and Metastasis Reviews 25: 409-416.
40. Osborne C, Wilson P, Tripathy D (2004) Oncogenes and tumor suppressor genes in breast cancer: potential diagnostic and therapeutic applications. The oncologist 9: 361-377. (Pubitemid 39014548)
41. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative CT method. Nature protocols 3: 1101-1108. (Pubitemid 351818697)
42. Edge SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of surgical oncology 17: 1471-1474.